Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia

Medical Mycology

Volumn 52, Issue 5, 2014, Pages 453-459

  Prüller, Florian ^a   Wagner, Jasmin ^a   Raggam, Reinhard B ^a   Hoenigl, Martin ^a   Kessler, Harald H ^a   Truschnig Wilders, Martie ^a   Krause, Robert ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

(1 3) beta D glucan; candidemia; invasive fungal infection; laboratory diagnosis; single sample testing

Indexed keywords

(1-3) BETA D GLUCAN; POLYSACCHARIDE; UNCLASSIFIED DRUG; BETA 1,3 GLUCAN; BETA GLUCAN; FUNGUS ANTIGEN;

ACCURACY; ARTICLE; AUTOMATION; BLOOD CULTURE; CANDIDEMIA; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HEALTH CARE COST; HUMAN; LABORATORY DIAGNOSIS; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; STANDARD; BLOOD ANALYSIS; COST; FUNGUS TEST KIT; HEMATOLOGY ANALYZER; MAJOR CLINICAL STUDY; BLOOD; CANDIDA; DEVICES; ECONOMICS; ISOLATION AND PURIFICATION; LABORATORY AUTOMATION; MICROBIOLOGY; PROCEDURES; REPRODUCIBILITY; TIME;

ANTIGENS, FUNGAL; AUTOMATION, LABORATORY; BETA-GLUCANS; CANDIDA; CANDIDEMIA; HUMANS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84901681710     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myu023     Document Type: Article

References (36)

1. Ellepola ANB, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J Microbiol 2005; 43(Spec No): 65-84.
2. Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med 2012; 125(Suppl 1): 14-24.
3. Pagano L, Caira M, Candoni A et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91: 1068-1075.
4. Hoenigl M, Zollner-Schwetz I, Sill H et al. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies. Mycoses 2011; 54: 454-459.
5. Karageorgopoulos DE, Vouloumanou EK, Ntziora F et al. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011; 52: 750-770.
6. Arendrup MC, Sulim S, Holm A et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 2011; 49: 3300-3308.
7. Groll AH, Shah PM, Mentzel C et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
8. Berenguer J, Buck M, Witebsky F et al. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive can-didiasis. Disseminated versus single-organ infection. Diagn Mi-crobiol Infect Dis 1993; 17: 103-109.
9. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49: 3640-3645.
10. Falagas ME, Tassios PT. Enhanced and earlier detection of bac-teremia and fungemia by multiplex polymerase chain reaction: how much enhanced, how much earlier, and at what cost? Crit Care Med 2008; 36: 1660-1661.
11. Reiss E, Obayashi T, Orle K, Yoshida M, Zancopé-Oliveira RM. Non-culture based diagnostic tests for mycotic infections. Med Mycol 2000; 38(Suppl 1): 147-159.
12. Odabasi Z, Mattiuzzi G, Estey E et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myeloge-nous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199-205.
13. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609-622.
14. Saitô H, Yoshioka Y, Uehara N et al. Relationship between conformation and biological response for (1-3)-beta-D-glucans in the activation of coagulation factor G from limulus amebocyte lysate and host-mediated antitumor activity. Demonstration of single-helix conformation as a stimulant. Carbohydr Res 1991; 217: 181-190.
15. Aketagawa J, Tanaka S, Tamura H, Shibata Y, Saitô H. Activation of limulus coagulation factor G by several (1--beta-D-glucans: comparison of the potency of glucans with identical degree of polymerization but different conformations. J Biochem 1993; 113: 683-686.
16. Tamura H, Arimoto Y, Tanaka S et al. Automated kinetic assay for endotoxin and (1--beta-D-glucan in human blood. Clin Chim Acta 1994; 226: 109-112.
17. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillo-sis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37(Suppl 3): S265-S280.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
19. Lalkhen AG, McCluskey A. Clinical tests: sensitivity and specificity. Contin Educ Anaesth Crit Care Pain 2008; 8: 221-223.
20. Sensitivity, Specificity, and Relatives. In: Vidakovic B, ed. Statistics for Bioengineering Sciences. New York, NY: Springer; 2011:109-130.
21. Alexander BD, Pfaller MA. Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis 2006; 43(Suppl 1): 15-27.
22. Lamoth F, Cruciani M, Mengoli C et al. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 2012; 54: 633-643.
23. Nguyen MH, Wissel MC, Shields RK et al. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54:1240-1248.
24. Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. (1, 3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis 2012; 55: 521-526.
25. Clancy CJ, Nguyen MH. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013; 56: 1284-1292.
26. Pickering JW, Sant HW, Bowles CAP, Roberts WL, Woods GL. Evaluation of a (1--beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005; 43: 5957-5962.
27. Kanda H, Kubo K, Hamasaki K et al. Influence of various hemodialysis membranes on the plasma (1--beta-D-glucan level. Kidney Int 2001; 60: 319-323.
28. Kato A, Takita T, Furuhashi M et al. Elevation of blood (1--beta-D-glucan concentrations in hemodialysis patients. Nephron 2001; 89: 15-19.
29. Usami M, Ohata A, Horiuchi T et al. Positive (1--beta-D-glucan in blood components and release of (1--beta-D-glucan from depth-type membrane filters for blood processing. Transfusion 2002; 42: 1189-1195.
30. Huszár G, Jenei B, Szabó G, Medgyesi GA. Detection of pyrogens in intravenous IgG preparations. Biologicals 2002; 30: 77-83.
31. Held J, Kohlberger I, Rappold E, Busse Grawitz A, Häcker G. Comparison of (1--β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol 2013; 51: 1158-1164.
32. Digby J, Kalbfleisch J, Glenn A et al. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 2003; 10: 882-885.
33. Miyazaki T, Kohno S, Mitsutake K et al. Plasma (1--beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 1995; 33: 3115-3118.
34. Ogawa M, Hori H, Niiguchi S, Azuma E, Komada Y. False-positive plasma (1--beta-D-glucan test following im-munoglobulin product replacement in an adult bone marrow recipient. Int J Hematol 2004; 80: 97-98.
35. Xie Z, Thompson A, Sobue T et al. Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing. J Infect Dis 2012; 206: 1936-1945.
36. Lass-Flörl C, Resch G, Nachbaur D et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis 2007; 45: 101-104.